✦ LIBER ✦

Is patient age a factor in the occurrence of prostate-specific antigen bounce phenomenon after external beam radiotherapy for prostate cancer?

✍ Scribed by Charles J. Rosser; Ashish M. Kamat; Xuemei Wang; Kim-Anh Do; Ricardo F. Sanchez-Ortiz; Deborah A. Kuban; Andrew K. Lee; Rex Cheung; Ramsey Chichakli; Louis L. Pisters

Book ID: 116944987
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 145 KB
Volume: 66
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2005.02.026

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prostate-specific antigen bounce after e

Prostate-specific antigen bounce after external beam radiotherapy plus high-dose-rate brachytherapy boost for definitive management of localized prostate cancer

✍ Anuj V. Peddada; Scott B. Jenings; Patrick O. Faricy; Richard A. Walsh III; Greg 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 131 KB

The importance of an exponential prostat

The importance of an exponential prostate-specific antigen decline after external beam radiotherapy for intermediate risk prostate cancer

✍ Guila Delouya; Gabriel Kaufman; Marie-Pierre Sylvestre; Thu-Van Nguyen; Jean-Pau 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 215 KB

Evaluation of radiation effect, tumor di

Evaluation of radiation effect, tumor differentiation, and prostate specific antigen staining in sequential prostate biopsies after external beam radiotherapy for patients with prostate carcinoma

✍ Juanita M. Crook; Yasir A. Bahadur; Susan J. Robertson; Gad A. Perry; Bernd A. E 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB 👁 2 views

tients with residual tumor in 1 or more biopsies at 10 -78 months of follow-up Regional Cancer Centre, Ottawa, Ontario, Canwere selected for review. All patients had undergone biopsy on more than one ada. occasion. The 198 biopsies were stained for PSA, high molecular weight keratin,

A zero PSA slope in posttreatment prosta

A zero PSA slope in posttreatment prostate-specific antigen supports cure of patients with long-term follow-up after external beam radiotherapy for localized prostate cancer

✍ Robert Takamiya; Vivian Weinberg; C.Dale Young; Howard Sandler; Peter McLaughlin 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Biochemical and clinical significance of

Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone : A multiinstitutional pooled analysis

✍ Eric M. Horwitz; Lawrence B. Levy; Howard D. Thames; Patrick A. Kupelian; Alvaro 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 1 views

Recurrence-free survival rates after ext

Recurrence-free survival rates after external-beam radiotherapy for patients with clinical T1–T3 prostate carcinoma in the prostate-specific antigen era : What should we expect?

✍ Deepak Khuntia; Chandana A. Reddy; Arul Mahadevan; Eric A. Klein; Patrick A. Kup 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

## Abstract ## BACKGROUND The objective of the current study was to report biochemical recurrence–free survival (bRFS) rates among men with T1–T3 prostate carcinoma who were treated with external‐beam radiotherapy (RT) at the Cleveland Clinic Foundation (Cleveland, OH). ## METHODS In total, 1352